Anne Wojcicki’s nonprofit TTAM Research Institute secured 23andMe’s assets for $305 million, surpassing Regeneron’s bid in bankruptcy court proceedings. The acquisition includes commitments to consumer data privacy and ongoing research, aiming to maintain the company's foundational vision of empowering individuals through genomic health data while enhancing protections and transparency.